WallStSmart
BMEZ

BlackRock Health Sciences Trust II

NYSE: BMEZ · FINANCIAL SERVICES · ASSET MANAGEMENT

$14.12
-0.97% today

Updated 2026-06-05

Market cap
$904.39M
P/E ratio
5.70
P/S ratio
8.86x
EPS (TTM)
$2.54
Dividend yield
52W range
$13 – $15
Volume
0.2M

BlackRock Health Sciences Trust II (BMEZ) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201920202021202220232024
Operating cash flow$-1.52B$107.17M$-21.56M$-874045.00$32.02M$65.52M
Capital expenditures$0.00$0.00$4.00$0.00$0.00$0.00
Depreciation
Stock-based comp
Free cash flow$-1.52B$107.17M$-21.56M$-874045.00$32.02M$65.52M
Investing cash flow
Financing cash flow
Dividends paid$33.34M$96.98M$29.00M$32.73M$35.10M$35.92M
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

How profitable is BMEZ?

In its most recent fiscal year, BMEZ ran a gross margin of 100.00%, an operating margin of 3.85%, and a net margin of 97.44%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does BMEZ generate?

BMEZ produced $65.52M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BMEZ's balance sheet healthy?

BMEZ holds $71339.00 in cash and equivalents against — in long-term debt, on $768.57M of shareholder equity. That debt is best read against the cash flow the business throws off each year.